Access Bio Stock Cash And Equivalents
| 950130 Stock | KRW 6,600 100.00 1.54% |
Access Bio fundamentals help investors to digest information that contributes to Access Bio's financial success or failures. It also enables traders to predict the movement of Access Stock. The fundamental analysis module provides a way to measure Access Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Access Bio stock.
Access |
Access Bio Company Cash And Equivalents Analysis
Access Bio's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Access Bio Cash And Equivalents | 167.93 M |
Most of Access Bio's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Access Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Access Bio has 167.93 M in Cash And Equivalents. This is 79.54% lower than that of the Healthcare sector and significantly higher than that of the Health Care Equipment & Supplies industry. The cash and equivalents for all Republic of Korea stocks is 93.79% higher than that of the company.
Access Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Access Bio's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Access Bio could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics of similar companies.Access Bio is currently under evaluation in cash and equivalents category among related companies.
Access Fundamentals
| Return On Equity | 108.02 | |||
| Return On Asset | 0.35 | |||
| Profit Margin | 0.40 % | |||
| Operating Margin | 0.55 % | |||
| Current Valuation | 1.03 T | |||
| Shares Outstanding | 26.79 M | |||
| Shares Owned By Insiders | 25.25 % | |||
| Shares Owned By Institutions | 0.08 % | |||
| Price To Earning | 149.71 X | |||
| Price To Sales | 1.44 X | |||
| Revenue | 441.37 M | |||
| Gross Profit | 90.63 B | |||
| EBITDA | 69.95 B | |||
| Net Income | 166.09 M | |||
| Cash And Equivalents | 167.93 M | |||
| Cash Per Share | 828.78 X | |||
| Total Debt | 10.13 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 16.48 X | |||
| Book Value Per Share | 2,289 X | |||
| Cash Flow From Operations | 137.9 M | |||
| Number Of Employees | 69 | |||
| Beta | 0.28 | |||
| Market Capitalization | 292.03 B | |||
| Total Asset | 372.85 M | |||
| Retained Earnings | 18.8 B | |||
| Working Capital | 43.68 B | |||
| Current Asset | 45.78 B | |||
| Current Liabilities | 2.1 B | |||
| Net Asset | 372.85 M |
About Access Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Access Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Access Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Access Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Access Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Access Bio's short interest history, or implied volatility extrapolated from Access Bio options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |